• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

OCO Biomedical

Anonymous board for OCO Biomedical
Replies
2
Views
3K
anonymous
Replies
4
Views
4K
anonymous